Myriad Genetics: Diagnostic product maker thrives despite economy

Utah-based Myriad Genetics turned a loss into a record $21.2 million profit in its fiscal second quarter, its stock soaring Tuesday about $12, or 17 percent, on the news. "The severe recession that grips the country appears to be affecting most...